FDA Approved: VALSARTAN — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves a supplemental application for VALSARTAN by Amneal Pharmaceuticals LLC (ANDA 204011) to support the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)